| ||
Ohr Pharmaceutical Announces $2.9 Million Financing MarketWatch (press release) Dr. Irach B. Taraporewala, CEO of Ohr Pharmaceutical, added, "This financing will allow us to comfortably achieve several upcoming milestones in our Squalamine eye drop and OHR/AVR118 clinical programs in the remainder of 2012 and 2013. We would ... See all stories on this topic » | ||
| ||
Pfizer complains against Zydus on US patent violation Business Standard For the second time in a month, a complaint of infringement of patent has been filed against Zydus Pharmaceuticals (USA), a wholly-owned subsidiary of Ahmedabad-based pharma major Cadila Health-care (Zydus Cadila) at a US district court. See all stories on this topic » | ||
Belviq by Arena Pharmaceuticals gets approved by FDA allvoices After a long time - more than 10 years -, the Food and Drug Administration in the United States has approved a drug for weight loss for the public. See all stories on this topic » | ||
| ||
Watson Pharmaceuticals Incorporated Stock Rating Reaffirmed by Needham ... Daily Political Watson Pharmaceuticals Incorporated (NYSE: WPI)'s stock had its hold rating restated by analysts at Needham & Company in a research report issued to. See all stories on this topic » | ||
HC dismisses Sun Pharma's appeal on Acucal trademark Economic Times The decision came after due diligence by the court on various scientific aspects related to the suit apart from traditional crosschecks like trademark infringement, phonetic and visual similarities. See all stories on this topic » | ||
| ||
Karen M. Jones: Pharmaceuticals aren't paying off physicians Delmarva Daily Times RE: 'Doctors ring in big bucks from drug companies,' June 10. See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment